课题基金 / 基金详情

Genetic Frontotemporal Dementia Initiative (GENFI) in Canada: Combined Investigation of Clinical, MRI, Genomic, and Epigenomic Biomarkers

Genetic Frontotemporal Dementia Initiative (GENFI) in Canada: Combined Investigation of Clinical, MRI, Genomic, and Epigenomic Biomarkers
加拿大遗传性额颞叶痴呆计划 (GENFI)：临床、MRI、基因组和表观基因组生物标志物的联合研究
批准号：
435055
负责人：
Masellis Mario
金额：
$82.2万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
未结题
起止时间：
2020-10-01 至 2025-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=435055&lang=en
关键词：
C9orf72 Dna Methylation Epigenomics Frontotemporal Dementia Genomics Grn Mapt Mri Quantitative Traits Single Nucleotide Polymorphisms

项目摘要

项目成果

Masellis Mario的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There have been three major genes discovered that cause familial forms of frontotemporal dementia (FTD), a devastating group of disorders associated with personality and behavioural changes and/or language difficulties in those suffering. These cognitive
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TACKLing the challenges of PREsymptomatic sporadic Dementia (TACKL-PRED)
NeuroCovid: European Solution for the Global Problem of dementia and Neurodegeneration following COVID-19 (EU-Connect)
  • 批准号：
    467283
  • 项目类别：
    Operating Grants
  • 资助金额：
    $0.0万
  • 财政年份：
    2021
  • 负责人：
    Masellis Mario
  • 依托单位：
    University of Toronto
Mid Career Investigator Prize in Research in Aging: Genetic Frontotemporal Dementia Initiative (GENFI) in Canada: Combined Investigation of Clinical, MRI, Genomic, and Epigenomic Biomarkers
Genetic Frontotemporal Dementia Initiative (GENFI) in Canada
海外基金